| Abington Adult Medical Associates | |
|
1235 Old York Rd Suite 214 Abington PA 19001-3800 | |
| (215) 481-4811 | |
| (215) 576-1787 |
| Full Name | Abington Adult Medical Associates |
|---|---|
| Speciality | Internal Medicine |
| Location | 1235 Old York Rd, Abington, Pennsylvania |
| Authorized Official Name and Position | Michael B Walsh (SENIOR VP FINANCE) |
| Authorized Official Contact | 2154812850 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Abington Adult Medical Associates Po Box 826594 Philadelphia PA 19182-6594 Ph: (215) 481-4811 | Abington Adult Medical Associates 1235 Old York Rd Suite 214 Abington PA 19001-3800 Ph: (215) 481-4811 |
| NPI Number | 1063526556 |
|---|---|
| Provider Enumeration Date | 08/19/2006 |
| Last Update Date | 10/12/2022 |
| Medicare PECOS PAC ID | 3274437736 |
|---|---|
| Medicare Enrollment ID | O20040330000678 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063526556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Mary Ellen Langford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114923802 PECOS PAC ID: 6901882547 Enrollment ID: I20040625000188 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Kathleen Mckenna Coppola |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932197837 PECOS PAC ID: 0244217941 Enrollment ID: I20040701000095 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Donna Graham |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598761694 PECOS PAC ID: 7911972336 Enrollment ID: I20040830000659 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Richard Eisenstaedt |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1679579916 PECOS PAC ID: 8022060326 Enrollment ID: I20050215000613 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Rachel Leah Ramirez |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1710950019 PECOS PAC ID: 6608881479 Enrollment ID: I20090918000400 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Margot Boigon |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811993140 PECOS PAC ID: 1052449204 Enrollment ID: I20100507000457 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Dimple C Patel |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356503742 PECOS PAC ID: 3870765084 Enrollment ID: I20111012000609 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Nataliya Dementovych |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083875637 PECOS PAC ID: 4486810587 Enrollment ID: I20120718000030 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Jamie A Swanson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700049905 PECOS PAC ID: 1153516778 Enrollment ID: I20140218001297 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Sara J Collins |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558659250 PECOS PAC ID: 5890947428 Enrollment ID: I20140822001014 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Danila Deliana |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1316100159 PECOS PAC ID: 9032270475 Enrollment ID: I20150707001005 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Todd H Goldberg |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1639122492 PECOS PAC ID: 8921197625 Enrollment ID: I20170620002869 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Matthew F Watto |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1730404591 PECOS PAC ID: 4183868599 Enrollment ID: I20171108000748 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
| Provider Name | Rehan Saeed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538655832 PECOS PAC ID: 0244582500 Enrollment ID: I20210908002285 |
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
News Archive
Providence Saint John's Health Center is partnering with Children's Hospital Los Angeles Medical Group to raise the level of care for the most fragile newborns in the medical center's Neonatal Intensive Care Unit (NICU), bringing world class neonatal care to Santa Monica and the surrounding Westside communities.
Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) provided an update on pre-clinical activities in preparation of its first IND filing with the Food and Drug Administration for its retinal pigment epithelium (RPE) cell program for the treatment of various eye diseases.
It takes women aged over 65 the longest to arrive at the emergency department after the onset of myocardial infarction symptoms. As a consequence, valuable time is lost to reopen the occluded blood vessels and limit the damage to the myocardium.
Cyclacel Pharmaceuticals, Inc. announced that new interim data from an ongoing, multicenter, Phase 2 clinical trial of oral sapacitabine, the Company's lead product candidate, will be presented at an oral poster discussion during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois on Monday, June 7, 2010.
› Verified 2 days ago
Abington Primary Care Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1400 Old York Road, Suite A, Abington, PA 19001 Phone: 215-576-1766 Fax: 215-576-1784 | |
Patient First - Abington Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 938 Old York Rd, Abington, PA 19001 Phone: 267-620-0237 Fax: 267-620-0238 | |
Palliative Medicine Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Dixon Building, Suite 201, Abington, PA 19001 Phone: 215-481-6839 Fax: 215-481-3515 | |
Geriatric Assessment Of Abington Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1245 Highland Ave, Suite 305, Abington, PA 19001 Phone: 215-481-5640 | |
Abington Plaza Medical Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1235 Old York Rd, Suite 113, Abington, PA 19001 Phone: 215-481-6180 Fax: 215-481-6341 | |
Amh Medical Staff Service Fund Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 |